Stock CHRO CHROMOCELL THERAPEUTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Chromocell Therapeutics Corporation

Equities

CHRO

US1711261057

Biotechnology & Medical Research

Market Closed - Nyse
Other stock markets
 04:10:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
1.74 USD -1.69% Intraday chart for Chromocell Therapeutics Corporation +16.00% 0.00%
Apr. 16 Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 21 Chromocell Therapeutics Corporation Announces Formal Launch of Eye Pain Treatment Program CI

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales 1 0.1999 - - -
EBITDA - - -1.628 -
EBIT 1 -1.354 -0.839 -2.318 -6.862
Operating Margin -677.16% - - -
Earnings before Tax (EBT) 1 -0.6606 -0.5954 -2.459 -7.381
Net income 1 -0.6606 -0.5954 -2.459 -7.381
Net margin -330.4% - - -
EPS - - -5.648 -5.782
Free Cash Flow - - - -0.6406
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 9/6/22 9/6/22 5/1/23 4/16/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 0.24 1.1 0.49 1.17
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) - - -0.2982 x -
Free Cash Flow - - - -0.64
ROE (net income / shareholders' equity) - 16.4% 66.6% 145%
ROA (Net income/ Total Assets) - - - -5,663%
Assets 1 - - - 0.1303
Book Value Per Share - - -3.340 -1.650
Cash Flow per Share - - 0.0500 0.0200
Capex - - - -
Capex / Sales - - - -
Announcement Date 9/6/22 9/6/22 5/1/23 4/16/24
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
CHROMOCELL THERAPEUTICS CORPORATION Stock Chromocell Therapeutics Corporation
0.00% 10.23M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.65% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+6.75% 101B
ARGENX SE Stock argenx SE
+5.71% 23.07B
BIONTECH SE Stock BioNTech SE
-12.60% 22.23B
GENMAB A/S Stock Genmab A/S
-9.70% 18.05B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.18B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.17% 16.94B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.12% 14.07B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.47% 12.35B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. CHRO Stock
  4. Financials Chromocell Therapeutics Corporation